A homegrown vaccine
New Zealand needs the capacity to develop and manufacture our own vaccines.
Planning in the face of covid-19 is complex because we've never had this particular virus before, says Sir Peter Gluckman.
The illusion of privacy has been shattered. Journalists exposing the truth of our smartphones.
Ransomware is a term that’s been firmly in the news this year with several high-profile attacks hitting the headlines.
The best single predictor of vaccine uptake per US state is the share of the population that believes the human race has always existed.
New Zealand’s new stock market for SMEs, Catalist, could boost growth among businesses that are too small for the NZX.
Sorry, nothing was found. Please try a different set of filters.
Boards and directors are facing myriad challenges and many of these will only increase in scale and importance in 2023.
In this issue we explore governance of the new national health agencies and active regulation of climate, privacy and supermarkets.